Aristotle (ARTL) Reports Q1 Results, Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Aristotle (ARTL) Reports Q1 Results, Provides Business Update

Artelo Biosciences Reports First Quarter Fiscal Year 2022 Financial Results and Provides Business Update

January 12, 2022 8:30 AM EST

Complete Enrollment of Phase 1 CAReS Trial Anticipated by End of First Quarter of Calendar Year 2022

$26.4 Million in Cash and Marketable Securities as of November 30, 2021

SOLANA BEACH, Calif., Jan. 12, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical stage pharmaceutical company developing therapeutics that modulate lipid-signaling pathways, including the... More